lipegfilgrastim

A long acting glyco-pegylated recombinant form of human granulocyte colony-stimulating factor (G-CSF), with hematopoietic activity. Similar to G-CSF… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2016
0246820122016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
To assess the basis of the different half-lives of long-acting human granulocyte colony-stimulating factor (G-CSF) drugs, the… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Neutropenia and febrile neutropenia (FN) are frequent and potentially fatal toxicities of myelosuppressive anticancer treatments… (More)
  • figure 1
  • table 1
  • table 1
Is this relevant?
2015
2015
PURPOSE The aim of this study was to demonstrate lipegfilgrastim superiority versus placebo in adults with non-small cell lung… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
  • International journal of nanomedicine
  • 2015
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of… (More)
Is this relevant?
2015
2015
Lipegfilgrastim is a once-per-cycle, fixed-dose, glycoPEGylated recombinant granulocyte colony-stimulating factor (G-CSF… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
Review
2015
Review
2015
Chemotherapy, irradiation, and other agents are widely used to target the process of cell division in neoplastic cells. However… (More)
  • figure 1
Is this relevant?
Review
2015
Review
2015
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of… (More)
Is this relevant?
2014
2014
This dose-ranging study was conducted to identify the optimal fixed dose of lipegfilgrastim compared with pegfilgrastim 6.0 mg… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
Is this relevant?
2014
2014
OBJECTIVE Two phase I, single-blind (subject blinded to treatment), randomized studies were conducted to assess the… (More)
Is this relevant?